Mayne Pharma Group Limited announced a series of changes to the leadership team. The key changes to the group leadership team are: Stefan Cross, former President of Mayne Pharma USA has been appointed as Chief Commercial Officer with responsibility for commercial product operations across the Group including Generic Products and Specialty Brands business units based in the US along with Australian commercial operations. John Ross, former EVP of Metrics Contract Services has been appointed as President, Mayne Pharma USA with responsibility for Metrics Contract Services and US operations including manufacturing, quality, supply chain and business integration. Craig Boyd, former EVP of Generic Products, has been appointed as Executive Vice President, Specialty Brands. Gadi Ben-Nissim has joined the leadership team as Executive Vice President, Generic Products. Kimberly McClintock has joined the leadership team as Executive Vice President, Metrics Contract Services.